Abbott Laboratories (ABL.MU)
| Previous close | 99.17 |
| Open | 98.49 |
| Bid | 98.23 x N/A |
| Ask | 98.49 x N/A |
| Day's range | 98.49 - 98.49 |
| 52-week range | 85.62 - 110.36 |
| Volume | |
| Avg. volume | 17 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Top Analyst Reports for Abbott, BP & Gilead
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BP p.l.c. (BP) and Gilead Sciences, Inc. (GILD), as well as two micro-cap stocks Smith-Midland Corporation (SMID) and Crimson Wine Group, Ltd. (CWGL).
- Insider Monkey
Is Abbott Laboratories (ABT) a Strong Buy Right Now?
We recently compiled a list of the 10 Best Dividend Kings to Buy for Safe Dividend Growth. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other dividend stocks. Investors often closely track the fluctuations of the stock market, eagerly expecting price increases. However, they may overlook […]
- Barrons.com
New Weight-Loss Drugs and Devices Are Coming This Week
Weight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American Diabetes Association are increasingly dominated by news on obesity drugs.
